ClinicalTrials.Veeva

Menu

Daily Disposable Contact Lens Tear Film Study

C

Ciba Vision

Status

Completed

Conditions

Myopia

Treatments

Device: delefilcon A contact lens
Device: narafilcon A contact lens

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01473160
P-347-C-014v2

Details and patient eligibility

About

The purpose of this study was to evaluate the pre-lens tear film stability of a new CE-marked daily disposable contact lens as compared to a commercially available daily disposable contact lens.

Enrollment

9 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Be of legal age of consent and sign Informed Consent document.
  • Willing and able to wear spherical contact lenses for 16 hours.
  • Willing and able to wear spherical contact lenses within the available range of powers.
  • Best corrected spectacle visual acuity equal or better than 20/25 or 6/7.5.
  • Other protocol-defined inclusion criteria may apply.

Exclusion criteria

  • Anterior segment infection, inflammation, or abnormality.
  • Any use of systemic medications for which contact lens wear could be contraindicated.
  • History of refractive surgery or irregular cornea.
  • Currently enrolled in any clinical trial.
  • Eye injury within twelve weeks prior to enrollment.
  • Other protocol-defined exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

9 participants in 2 patient groups

delefilcon A
Experimental group
Description:
Delefilcon A randomly assigned to one eye, with narafilcon A assigned to the fellow eye for contralateral wear. Both products will be worn for one day for 16 hours (+/- 1 hour).
Treatment:
Device: delefilcon A contact lens
narafilcon A
Active Comparator group
Description:
Narafilcon A randomly assigned to one eye, with delefilcon A assigned to the fellow eye for contralateral wear. Both products will be worn for one day for 16 hours (+/- 1 hour).
Treatment:
Device: narafilcon A contact lens

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems